AVFs, 53.4% required BAM, 1.7% were surgically revised, and 44.9% matured without interventions. A total of 186 AVFs underwent 217 BAMs; of those, 126 matured, 14 failed, and 46 were not used. There were 408 CDUSs performed: 174 in AVFs that had successful primary maturation, 201 that required BAM, and 33 that indicated AVF failure. Univariate logistic regression analysis was performed to compare CDUS findings in these groups. Duplex results in AVFs requiring BAM and those that failed to mature were similar and were combined for the final analysis (Table) . Based on generalized linear mixed model analysis, statistically significant predictors of AVF maturation were vein diameter $6 mm (odds ratio [OR], 38.7), VF $675 mL/min (OR, 5.0), absence of vein stenosis (OR, 35.6), and absence of stealing branches (OR, 21.6).
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Point-of-Care Ultrasound (POCUS) Use as Adjunct to Physical Examination and Its Impact on Arteriovenous Fistula Maturation
Sajjid Hossain, Amit Sharma, Luc Dubois, Audra Duncan, Guy DeRose, Adam Power. University of Western Ontario, Ontario, Canada
Objectives: Duplex ultrasound imaging as a preoperative assessment tool in clinic may help identify anatomical factors predictive of fistula maturation. Point-of-care ultrasound (POCUS) may decrease costs to the health care system and decrease time to access creation as compared to formal vein mapping. We sought to determine the impact of POCUS as an adjunct to physical examination on arteriovenous fistula maturation.
Methods: All consecutive patients undergoing first time dialysis access creation from December 2007 to December 2014 were retrospectively reviewed. Surgeons that routinely use POCUS to assess preoperative maximal vein diameter and quality were compared to surgeons that only relied on physical examination. All access and patency definitions were in accordance with the Society for Vascular Surgery reporting standards. The effect of POCUS on fistula maturation rate and fistula abandonment was analyzed using logistic regression, controlling for patient comorbidities, anticoagulant use, and location of fistula.
Results: A total of 316 patients were included in the study. Of these, 250 patients were assessed with physical examination only and 66 patients underwent POCUS by the vascular surgeon in clinic. There was no significant difference in mean age or comorbidities between the groups. The primary failure rate in the US group was 17% compared to 47% (P < .001) in the group of patients who did not undergo US examination. In patients without preoperative US there were higher rates of requiring new access creation (31% vs 9% P < .001) and fistula abandonment (66% vs 39% P < .001). Multivariable analysis showed absence of preoperative US was associated with a 3.56 greater risk of failure (95% CI 1.67-7.59; P ¼ .001) when compared to physical examination alone. Similarly, the rate of fistula abandonment was 2.63 times higher (95% confidence interval, 1.38-5.05; P ¼ .003) when US was not used preoperatively.
Conclusions: POCUS as an adjunct to physical examination for dialysis access patients leads to decreased rates of primary failure, new access creation, and fistula abandonment compared to patients who only undergo physical examination. Further studies are required to compare POCUS with formal preoperative vein mapping for arteriovenous fistula planning.
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Evaluation of an ePTFE Endograft Placed at the Time of Arteriovenous Fistula Creation to Prevent Juxta-anastomotic Stenosis and Improve Maturation and Long-Term Patency Rates
Oliver Aalami, Muhammad Majeed, Nathan K. Itoga. Stanford University, Stanford, Calif
Objectives: We evaluated the feasibility, safety and therapeutic advantage of an expanded polytetrafluoroethylene (ePTFE) endograft placement within the juxta-anastomotic segment of an arteriovenous fistula (AVF) at the time of fistula creation: The JuxtaBahn Procedure. This novel technique is an attempt to prevent juxta-anastomotic stenosis, which is a major contributing factor (40%-60%) leading to AVF failure. We are reporting the adverse effect profile and time-stamped outcome measures in terms of maturation, patency, reintervention frequency, stenosis patterns, and their effect on fistula viability. Methods: A retrospective, single-center database was reviewed for 22 AVFs created from 2012 to 2016 with the JuxtaBahn technique. These patients were treated at a single academic institution. A 6-mm Â 2.5-cm or 5.0-cm Viabahn endograft was deployed within the cephalic vein just distal to the anastomosis at the time of AVF creation. At the heel of the anastomosis, the anchoring suture was placed incorporating the artery, vein, and the graft. The hood of the anastomosis comprised native vein, and the remaining anastomosis was sutured in the standard end-toside fashion. Follow-up data were obtained from the electronic medical record.
Results: Technical success was achieved in all 22 patients enrolled, including 14 for radiocephalic and eight for brachiocephalic procedures. A mean follow-up of 26.6 months over 3 years showed 81.8% overall patency rate at 1 year vs 71% with standard procedure, 77.8% at 2 years, and 72.7% at 3 years. Primary patency rate at 1 and 2 years was 63.6% (vs 60% standard) and 50%, respectively. Overall maturation rate was 86.4% (19 fistulas) vs standard 76% (P < .41). Eighty percent (4 fistulas) of failures were within an average of 4 months (range, 2-7 months) of the creation and failed due to outflow obstruction (2), steal syndrome (1), and aneurysm formation (1). A total of seven fistulas (31.8%; >60% without JuxtaBahn) that developed juxta-anastomotic stenosis, only one failed (20%) attributing to juxta-anastomotic stenosis (vs 40%-60 % without JuxtaBahn). The remaining six (27.2%) stenosed fistulas underwent successful reinterventions. Interestingly, a new predilection site for stenosis emerged at the end of the endograft within the cephalic vein contributing to 71.4% (5) of stenosis events. There were no infections at the site of endograft placement throughout the study duration.
Conclusions: An ePTFE endograft placement at the time of AVF creation significantly lowers the juxta-anastomosis stenosis, increasing maturation rate and decreasing long-term need for reintervention compared to standard procedure. There is no additional infection risk associated with an endograft at the site of placement. Objectives: Safe delivery of large endovascular devices can be problematic in patients with inadequate iliofemoral access. We describe the technique and outcomes using carotid access for endovascular device delivery in patients with inadequate iliofemoral access.
Methods: Between January 2015 and January 2017, 60 patients presented with ascending aortic (n ¼ 3; Fig A) , descending aortic (n ¼ 3), or aortic valve (n ¼ 54) pathology who were poor candidates for conventional surgery. In addition, they had inadequate iliofemoral access for large endovascular device delivery. Vascular surgery provided carotid access for device delivery, which included direct exposure of the proximal common carotid artery at the level of the omohyoid muscle (Fig, B) , modification/shortening of the 14F to 22F device delivery sheath (Fig, C) , and intraoperative electroencephalographic monitoring to guide the need for femoraleto-carotid shunting during device delivery. Preoperative imaging included carotid duplex and computed tomography angiography of chest and lower neck.
Results: Right (32) and left (28) carotid access were both used for delivery of ascending (3) or descending aortic (3) covered stents or transcatheter aortic valves (54). Median age was 82 (range, 69-94) years with 50% (30 of 60) women. Procedural success was 100%. No patient required femoral-to-carotid shunting, and in 98% (59 of 60), a transverse carotid arteriotomy with primary repair was used (Fig, D) . In-hospital/30-day mortality was 5% (3 of 60). All patients were extubated in the operating room without any operative neurologic complications. Perioperative strokes occurred in two patients (3.3%) who had transcatheter aortic valve replacements. One stroke occurred on postoperative day 4 and involved a retinal artery occlusion on the carotid access side, and one stroke involved the contralateral hemisphere to carotid access. Median length of stay was 3 days (range 1-9 days) and 96.5% (55 of 57) of surviving patients were discharged to home. With a median follow-up of 12 months (range 1-24 months), survival remains 92% (55 of 60) with no late carotid access complications or strokes.
Conclusions: Delivery of large endovascular devices in patients with inadequate iliofemoral access can be safely performed using carotid access by incorporating a cerebral protection strategy guided by intraoperative electroencephalographic EEG monitoring and facilitated by vascular surgery.
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